These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 19733524)

  • 1. [High cardiovascular complications in systemic lupus erythematosus: physiopathology and risk management].
    Boffa JJ; Rougier JP; Noël N; Ronco P
    Nephrol Ther; 2009 Dec; 5(7):595-602. PubMed ID: 19733524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
    Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
    J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Premature vascular damage in systemic lupus erythematosus.
    Kaplan MJ
    Autoimmunity; 2009 Nov; 42(7):580-6. PubMed ID: 19657770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.
    Bruce IN
    Rheumatology (Oxford); 2005 Dec; 44(12):1492-502. PubMed ID: 16234277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome].
    Sarzi-Puttini P; Atzeni F; Carrabba M
    Minerva Med; 2003 Apr; 94(2):63-70. PubMed ID: 12858154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosus.
    Lee AB; Godfrey T; Rowley KG; Karschimkus CS; Dragicevic G; Romas E; Clemens L; Wilson AM; Nikpour M; Prior DL; Best JD; Jenkins AJ
    Intern Med J; 2006 Apr; 36(4):237-43. PubMed ID: 16640741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk profile in systemic lupus erythematosus and rheumatoid arthritis: a comparative study of female patients.
    Santos MJ; Vinagre F; Silva JJ; Gil V; Fonseca JE
    Acta Reumatol Port; 2010; 35(3):325-32. PubMed ID: 20975635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiovascular risk profile in a Portuguese cohort of SLE Portuguese patients].
    Duarte C; Couto M; Vaz C; Inês L; Malcata A
    Acta Reumatol Port; 2009; 34(2B):349-57. PubMed ID: 19727047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic lupus erythematosus, atherosclerosis, and autoantibodies.
    Zampieri S; Iaccarino L; Ghirardello A; Tarricone E; Arienti S; Sarzi-Puttini P; Gambari P; Doria A
    Ann N Y Acad Sci; 2005 Jun; 1051():351-61. PubMed ID: 16126977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SLE, atherosclerosis and cardiovascular disease.
    Frostegård J
    J Intern Med; 2005 Jun; 257(6):485-95. PubMed ID: 15910552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic lupus erythematosus and cardiovascular disease.
    Frostegård J
    Lupus; 2008 May; 17(5):364-7. PubMed ID: 18490408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk in systemic lupus erythematosus--evidence of increased oxidative stress and dyslipidaemia.
    Nuttall SL; Heaton S; Piper MK; Martin U; Gordon C
    Rheumatology (Oxford); 2003 Jun; 42(6):758-62. PubMed ID: 12730535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: A case-control study.
    Bessant R; Duncan R; Ambler G; Swanton J; Isenberg DA; Gordon C; Rahman A
    Arthritis Rheum; 2006 Dec; 55(6):892-9. PubMed ID: 17139666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular events in systemic lupus erythematosus and rheumatoid arthritis : emerging concepts, early diagnosis and management.
    Chogle AR; Chakravarty A
    J Assoc Physicians India; 2007 Jan; 55():32-40. PubMed ID: 17444342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of plasma interleukin-18 concentrations to traditional and non-traditional cardiovascular risk factors in patients with systemic lupus erythematosus.
    Tso TK; Huang WN; Huang HY; Chang CK
    Rheumatology (Oxford); 2006 Sep; 45(9):1148-53. PubMed ID: 16527878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Markers of inflammation and atherosclerosis in Egyptian patients with systemic lupus erythematosus.
    Sabry AA; Elbasyouni SR; Kalil AM; Abdel-Rahim M; Mohsen T; Sleem A
    Nephrology (Carlton); 2006 Aug; 11(4):329-35. PubMed ID: 16889573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular disease risk awareness in systemic lupus erythematosus patients.
    Scalzi LV; Ballou SP; Park JY; Redline S; Kirchner HL
    Arthritis Rheum; 2008 May; 58(5):1458-64. PubMed ID: 18438863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus: understanding management strategies.
    Turano L
    J Cardiovasc Nurs; 2013; 28(1):48-53. PubMed ID: 22210142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atherosclerosis in systemic lupus erythematosus.
    Sherer Y; Zinger H; Shoenfeld Y
    Autoimmunity; 2010 Feb; 43(1):98-102. PubMed ID: 20014976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atherosclerosis in systemic lupus erythematosus].
    Tazi Mezalek Z; Harmouche H; Ammouri W; Maamar M; Adnaoui M; Cacoub P
    Presse Med; 2014 Oct; 43(10 Pt 1):1034-47. PubMed ID: 25201598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.